Close Menu
Journal of Pharmacology and Pharmacotherapeutics
    Browse
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Past Issues
    • About
      • About Journal
      • Editorial Board
      • Bibliographic Listings
    • For Authors
      • Submission Guidelines
      • Submit Article
    • Contact
    Facebook X (Twitter) Instagram
    Journal of Pharmacology and PharmacotherapeuticsJournal of Pharmacology and Pharmacotherapeutics
    • Journal Homepage (SAGE)
    • Submission Guidelines
    Facebook X (Twitter) Instagram
    Submit
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Past Issues
    • About
      • About Journal
      • Editorial Board
      • Bibliographic Listings
    • For Authors
      • Submission Guidelines
      • Submit Article
    • Contact
    Journal of Pharmacology and Pharmacotherapeutics
    Home»Uncategorized»Association of NAT2 341C/T Gene Polymorphism and Risk of Periodontitis in Smokers: A Case-control Study
    Uncategorized

    Association of NAT2 341C/T Gene Polymorphism and Risk of Periodontitis in Smokers: A Case-control Study

    July 17, 20251 Min Read
    Share
    Facebook Twitter Email

    Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print.
    BackgroundPeriodontitis, an inflammatory disease, is caused by oral biofilm, and several risk factors propagate it. Smoking is a significant risk factor that increases the severity of the disease. ArylamineN-acetyltransferase 2 (NAT2) enzyme present in …

    Read Original Source

    Previous ArticleMultilevel Deep Learning Technique Based Classification of Lung Cancer as Per Tumor Node Metastasis Coding
    Next Article Pharmaceutical Frontliners: Community Pharmacists’ Contribution to Managing Medication Needs During a Health Crisis— The COVID-19 Era as an Example

    Related Articles

    Assessment Knowledge and Practice Among Pharmacy, Nursing, and Medical Students Regarding Hand Hygiene in Saudi Arabia

    Uncategorized

    Suzetrigine: A First-in-class NaV1.8 Inhibitor for Opioid-free Pain Management

    Uncategorized

    Cardiotoxicity Induced by Doxorubicin: Exploring Research Frontiers, Co-word Analysis, Trends, and Thematic Development

    Uncategorized
    Read Now
    Uncategorized

    Assessment Knowledge and Practice Among Pharmacy, Nursing, and Medical Students Regarding Hand Hygiene in Saudi Arabia

    January 24, 2026

    Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundHand hygiene is the key to prevent…

    Suzetrigine: A First-in-class NaV1.8 Inhibitor for Opioid-free Pain Management

    January 19, 2026

    Cardiotoxicity Induced by Doxorubicin: Exploring Research Frontiers, Co-word Analysis, Trends, and Thematic Development

    January 15, 2026
    Editor picks

    WITHDRAWN – Administrative Duplicate Publication: ML-powered Internet of Medical Things Structure for Heart Disease Prediction

    February 18, 2025

    Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions

    February 18, 2025

    Low Back Pain Management Through Bowel Lavage (Panchaprasrutik Basti)—A Single Arm Clinical Trial

    February 18, 2025
    About Journal
    About Journal

    The Journal of Pharmacology and Pharmacotherapeutics (JPP) is an open access, peer-reviewed journal that publishes high-quality articles pertaining to basic research and clinical studies in the domains of Pharmacology and Pharmacotherapeutics.

    We're accepting new partnerships right now.

    Email Us: editor.jpp@phcog.net

    Facebook X (Twitter) RSS
    Our Picks

    WITHDRAWN – Administrative Duplicate Publication: ML-powered Internet of Medical Things Structure for Heart Disease Prediction

    February 18, 2025

    Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions

    February 18, 2025

    Low Back Pain Management Through Bowel Lavage (Panchaprasrutik Basti)—A Single Arm Clinical Trial

    February 18, 2025
    Stay Connected

    Contact Editor-In-Chief
    Editor, Journal of Pharmacology and Pharmacotherapeutics
    Manuscript TechnoMedia LLP,
    #9, Vinnse Tower, Wheeler Road Extn.
    St. Thomas Town, 560084, Bangalore, INDIA
    Email: editor.jpp@phcog.net


    • Home
    • Site Map
    © 2026 JPharmacol.com Designed & Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.